南通江山农药化工股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》、《关于做好主板上市公司 2025 年半年度报告披露工作的重要提醒》 的要求，南通江山农药化工股份有限公司（以下简称"公司"）现将 2025 年半年 度主要经营数据披露如下： 注 1：上述产量含自用量、农药按含量折原药计算（下同）。 注 2：除草剂产品包括草甘膦、酰胺类等产品；杀虫剂产品包括敌百虫、敌敌畏、二嗪 磷等产品；氯碱产品包括烧碱、盐酸、液氯、次氯酸钠等产品，其中烧碱产销量 按 32%、48%烧碱实物量计算（下同）。 证券代码：600389 证券简称：江山股份 公告编号：临 2025-044 注 3：阻燃剂（磷系）产品包含 TCPP、BDP 产品（下同）。 | 主要产品 | 2025 | 年 | 1-6 月平 | 2024 月平 | 年 | 1-6 | 同期变动 | 第二季度环比 | | --- | --- | --- | - ...

Group 1 - The company plans to construct a production line for 500,000 tons per year of glyphosate in Guang'an, Sichuan [2] - There are no plans to produce 500,000 tons of glycine [2] - The company advises that significant operational information should be referenced in official announcements [2]

Core Viewpoint - New Qian has successfully passed the Hong Kong Stock Exchange listing hearing and is preparing to enter the capital market, marking a new chapter for the company in the food additives sector [1] Financial Performance - New Qian's revenue fluctuated over the past few years, with 2022 revenue at 761.5 million RMB, dropping to 446.9 million RMB in 2023, and recovering to 568.9 million RMB in 2024 [2] - Gross profit also experienced similar volatility, decreasing from 194.9 million RMB in 2022 to 79.9 million RMB in 2023, then rising to 101.9 million RMB in 2024 [2] - The company's net profit declined from 122 million RMB in 2021 to 44.7 million RMB in 2022, further decreasing to 43.4 million RMB in 2023, although adjusted net profit in 2023 showed a recovery to 53.6 million RMB [2] Cash Position and Dividend Policy - New Qian's cash and cash equivalents have been decreasing over the past three years, reaching 46.1 million RMB as of December 31, 2024 [3] - The company has been conservative in dividend distribution, declaring a mid-term dividend of approximately 8.6 million RMB in 2022, a final dividend of about 11.1 million RMB in 2023, and no dividends in 2024 [3] Corporate Governance - The company's governance structure exhibits a strong family influence, with key positions held by family members of Chairman Wang Xiaoqiang, including his son and spouse [3] - The shareholding structure reflects this family influence, with Wang Xiaoqiang holding 6.9% and New Qian Industrial holding 41.1%, collectively controlling 59.8% of the company [6] Shareholding Structure - Major shareholders include institutional investors such as Guo Xin Hong Sheng (9.8%), Fu Xing Investment (6%), and Xing Zheng Strategic Entrepreneurship (5.7%), which contribute to the company's capital vitality [6]

Summary of Key Points Core Viewpoint - The company, Shaanxi Beiyuan Chemical Group Co., Ltd., has decided to adjust the implementation schedule of its fundraising investment projects due to objective factors such as macroeconomic conditions and industry cycle fluctuations, while ensuring that the project content, investment total, and scale remain unchanged [1][11][12]. Group 1: Fundraising Overview - The company approved the public offering of up to 361,111,112 new shares, with total fundraising amounting to 343,999.07 million yuan [1][2]. - As of December 31, 2024, the actual use of the raised funds is 102,829.73 million yuan [4][10]. Group 2: Project Delay Details - The completion dates for several projects, including the 120,000 tons/year glycine project and the intelligent factory basic platform construction, have been extended to June 2025 due to various delays [6][10]. - The company plans to further adjust the completion dates for several projects to June 2027, including the 100,000 tons/year CPE and 20,000 tons/year CPVC projects [6][10]. Group 3: Reasons for Delay - The glycine project is delayed due to the immature industrial production setup of the mixed solvent method and the need for further testing and equipment selection [7][10]. - The intelligent factory project is affected by the need for system optimization and compliance with safety standards [8][10]. - The salt production project faces market challenges due to limited demand and economic viability [9][10]. Group 4: Measures to Ensure Completion - The company is actively working on plans to utilize by-products from the glycine project and is optimizing project management to ensure timely completion [7][8]. - Detailed optimization plans and strategies are being developed to ensure the intelligent factory project progresses smoothly [8][10]. - The company is conducting thorough market analysis and technical research to validate the feasibility of the salt production project [9][10]. Group 5: Impact of Project Delay - The delay in fundraising investment projects is based on careful consideration of objective circumstances and does not involve changes to project implementation subjects, fundraising purposes, or investment scales, thus not adversely affecting the company's operations or shareholder interests [10][11].

Group 1 - The company held its seventh meeting of the third supervisory board, which complied with legal and regulatory requirements [1] - The supervisory board unanimously agreed to abolish the supervisory board and transfer its powers to the audit committee, with amendments to the company's articles of association to take effect upon approval by the shareholders' meeting [1] - The voting results showed 10 votes in favor, 0 against, and 0 abstentions [1] Group 2 - The company agreed to adjust the completion dates for several fundraising investment projects, including the 120,000 tons/year glycine project and the smart factory infrastructure project, to June 2027 [2] - The supervisory board confirmed that the adjustments do not constitute a disguised change in the use of raised funds and are in the best interest of the company and all shareholders [2] - The voting results for this decision were also 10 votes in favor, 0 against, and 0 abstentions [2] Group 3 - The supervisory board approved the continued use of idle raised funds for cash management, allowing for investment in safe and liquid financial products up to RMB 2.6 billion [3] - This decision aims to enhance the efficiency of fund utilization without affecting the construction of fundraising projects [3] - The investment products include structured deposits, time deposits, and agreement deposits, with individual investment terms not exceeding 12 months [3]

证券代码： 600596 证券简称：新安股份 公告编号：2025-028 号 浙江新安化工集团股份有限公司 2024 年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》有关规定和披露要求，浙江新安化工集团股份有限公司（以下简称"公 司"）现将 2024 年度主要经营数据披露如下： | 主要产品 | 2024 年 1-12 月生 产量（吨） | 2024 年 1-12 月销 售量（吨） | 2024 年 1-12 月销售金 额（万元） | | --- | --- | --- | --- | | 农化原药 | 105,000.67 | 23,092.34 | 77,438.23 | | 农化制剂 | 214,784.72 | 200,825.03 | 337,441.13 | | 环体硅氧烷 | 195,835.99 | 111,989.87 | 146,756.74 | | 硅氧烷中间体 | 106,858.27 | 63 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2025-022 南通江山农药化工股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》、《关于做好主板上市公司 2025 年第一季度报告披露工作的重要提醒》 的要求，南通江山农药化工股份有限公司（以下简称"公司"）现将 2025 年第一 季度主要经营数据披露如下： 注 1：上述产量含自用量、农药按含量折原药计算（下同）。 | 主要原料 | 2025 年 1-3 月平 均进价（元/吨） | 2024 | 年 1-3 月平 均进价（元/吨） | 同期变动 比率（%） | 第一季度 环比变动 比率（%） | | --- | --- | --- | --- | --- | --- | | 甘氨酸 | 9,368.58 | | 9,532.20 | -1.72 | -4.04 | | 双甘膦 | 12,479.92 | | 12,831.86 | -2 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2025-021 南通江山农药化工股份有限公司 2024 年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》、《关于做好主板上市公司 2024 年年度报告披露工作的重要提醒》的 要求，南通江山农药化工股份有限公司（以下简称"公司"）现将 2024 年度主要 经营数据披露如下： 注 1：上述产量含自用量、农药按含量折原药计算（下同）。 注 2：除草剂产品包括草甘膦、酰胺类等产品；杀虫剂产品包括敌百虫、敌敌畏等产品； 氯碱产品包括烧碱、盐酸、液氯、次氯酸钠等产品，其中烧碱产销量按 32%、48% 烧碱实物量计算（下同）。 注 3：阻燃剂（磷系）产品包含 TCPP、BDP 产品（下同）。 本报告之经营数据未经审计，公司董事会提醒投资者审慎使用上述数据。 特此公告。 南通江山农药化工股份有限公司董事会 2025 年 4 月 22 日 2 杀虫剂产品 27,071.74 27,1 ...